Reding Andrew P. 4
4 · Predictive Oncology Inc. · Filed Oct 3, 2019
Insider Transaction Report
Form 4
Reding Andrew P.
Director
Transactions
- Award
Stock Option (right to buy)
2019-09-30+9,900→ 9,900 totalExercise: $0.51From: 2019-09-30Exp: 2029-09-30→ Common Stock (9,900 underlying)
Holdings
- 53
Common Stock, $.01 par value